[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Haematology](https://durgical.com/en/haematology/) › [Haemostasis, bleeding and thrombosis](https://durgical.com/en/haematology/areas/haemostasis/) › Immune thrombocytopenia: who needs treatment and why

# Immune thrombocytopenia: who needs treatment and why

- Treatment and support

In ITP the immune system destroys platelets. Many patients, especially children, need no treatment at all; the bleeding, not the number, decides.

Updated Nov 15, 2026

## Key points

- ITP = destruction plus reduced production; diagnosis of exclusion.
- Treat bleeding, not the number.
- Children: usually observe; adults: treat if very low or bleeding.
- Steroids first; immunoglobulin when speed matters.
- Second line: TPO receptor agonists, [rituximab](https://durgical.com/en/pharmacology/rituximab/), splenectomy.
- Platelet transfusion only for life-threatening bleeding.

On this page

- The basics Key points
- What it is
- How to think about it
- What to know
- How it is done (and why)
- Common traps
- Elsewhere in DurgiPedia

- Treatment The treatment ladder

- Safety Risks and precautions
- Monitoring and next step

- Study Test yourself

- Connections Connections

## What it is

[Immune thrombocytopenia (ITP)](https://durgical.com/en/conditions/immune-thrombocytopenia/) is an autoimmune fall in platelets below 100 × 10⁹/L, from [antibodies](https://durgical.com/en/biochemistry/enzymes/immunoglobulins/) that speed platelet destruction and also slow their production. It is primary when no cause is found and secondary when linked to another illness (lupus, [antiphospholipid syndrome](https://durgical.com/en/conditions/antiphospholipid-syndrome/), CLL, HIV, hepatitis C, H. pylori, drugs). It is called newly diagnosed in the first 3 months, persistent from 3 to 12 months and chronic after 12 months. In children it usually follows a viral infection and resolves; in adults it more often becomes chronic.

## How to think about it

Treat the patient, not the count. ITP platelets are few but young and sticky, so patients bleed less than the number suggests. Treatment is a ladder: watch first, then calm the immune attack quickly (steroids, immunoglobulin), then, if it keeps coming back, boost production ([thrombopoietin receptor agonists](https://durgical.com/en/pharmacology/classes/thrombopoietin-receptor-agonists/)) or remove the main destruction site ([spleen](https://durgical.com/en/anatomy/spleen/)) or the antibody makers (rituximab).

## What to know

- Children with skin bleeding only are usually observed, whatever the count; most recover within months.
- Adults are usually treated when the count is very low (commonly below about 30 × 10⁹/L) or when there is bleeding.
- First line: a short course of [corticosteroids](https://durgical.com/en/pharmacology/classes/corticosteroids/); intravenous immunoglobulin when a fast rise is needed (bleeding, surgery, delivery).
- Second line: thrombopoietin receptor agonists ([romiplostim](https://durgical.com/en/pharmacology/romiplostim/), [eltrombopag](https://durgical.com/en/pharmacology/eltrombopag/)), rituximab or splenectomy, chosen with the patient.
- Life-threatening bleeding: immunoglobulin, intravenous steroids and platelet transfusion together, with [tranexamic acid](https://durgical.com/en/pharmacology/tranexamic-acid/).

## How it is done (and why)

- Confirm ITP by exclusion: smear (no clumps, no abnormal cells), HIV and hepatitis C tests, and look for secondary causes.
- Grade bleeding: skin only, mucosal (mouth, nose, heavy periods) or serious (gut, brain).
- Decide whether to treat by bleeding, count, age, planned procedures, lifestyle and other drugs (anticoagulants, antiplatelets).
- If treating: short steroid course; add immunoglobulin for a faster rise.
- Relapse or no response after about 3 months: discuss thrombopoietin receptor agonists, rituximab or splenectomy.
- Before splenectomy, vaccinate against [pneumococcus](https://durgical.com/en/microbiology/streptococcus-pneumoniae/), [meningococcus](https://durgical.com/en/microbiology/neisseria-meningitidis/) and Haemophilus; it is usually delayed a year after diagnosis, as some recover.

## The treatment ladder

| Option | How it works | Speed | Main use or limit |
| --- | --- | --- | --- |
| Observation | Waits for spontaneous recovery | - | Most children; adults with safe counts and no bleeding |
| Corticosteroids | Reduce antibody-coated platelet destruction | Days | First line; keep courses short to limit side effects |
| Intravenous immunoglobulin | Blocks the spleen's receptors that capture coated platelets | 1–3 days | Bleeding, before surgery or delivery; effect is temporary |
| Thrombopoietin receptor agonists | Drive the marrow to make more platelets | 1–2 weeks | Persistent or chronic ITP; ongoing treatment |
| Rituximab | Removes the B cells that make the antibodies | Weeks | Second line; infection risk, vaccines before |
| Splenectomy | Removes the main destruction site | Days | Lasting response in many; lifelong infection risk |

## Risks and precautions

- Long or repeated steroid courses cause diabetes, bone loss, mood change and infections; guidelines limit their length.
- Thrombopoietin receptor agonists can raise the risk of clots and need [liver](https://durgical.com/en/anatomy/liver/) tests (eltrombopag) and count checks.
- After splenectomy, fever is an emergency because of overwhelming infection with encapsulated bacteria.
- In pregnancy, mild low platelets late in a normal pregnancy are usually [gestational thrombocytopenia](https://durgical.com/en/obstetrics-gynaecology/low-platelets-in-pregnancy-gestational-itp-preeclampsia-and-hellp-ttp-bleeding-d/), not ITP; delivery planning with the obstetric and anaesthesia teams matters for both.

## Monitoring and next step

- At diagnosis: count, smear, HIV, hepatitis C, and in adults consider H. pylori testing, blood group (for anti-D) and immunoglobulins.
- A marrow is not needed in typical ITP; it is done if the smear or other counts are abnormal, the patient is older, or treatment fails.
- On treatment: count weekly at first, then less often; blood [glucose](https://durgical.com/en/biochemistry/molecules/glucose/) and [blood pressure](https://durgical.com/en/physiology/systolic-diastolic-mean-and-pulse-pressure/) on steroids.
- Before rituximab: hepatitis B tests, because it can reactivate the virus.

## Common traps

- **Transfusing platelets routinely in ITP**: they are destroyed within hours; save them for life-threatening bleeding.
- **Treating a well child with skin bruising only because the count is low**: a low count alone is not a reason to treat.
- **Keeping adults on steroids for months to hold the count up**: move to second-line treatment instead.
- **Calling it ITP without checking for HIV, hepatitis C, lupus or drugs**: the cause changes the treatment.

## Test yourself

Think of the answer, then tap the question to see it.

## Why do patients with ITP usually bleed less than patients with the same count from marrow failure?

ITP platelets are young and large, released quickly by a working marrow, and work better than the older platelets of a failing marrow.

## How does intravenous immunoglobulin raise the platelet count quickly in ITP?

It blocks the Fc receptors on spleen macrophages that capture antibody-coated platelets, so fewer are destroyed for a few weeks.

## A five-year-old has petechiae two weeks after a cold, platelets of 15 × 10⁹/L and no mucosal bleeding. What is the usual management?

Observation with advice on warning signs: most childhood ITP resolves on its own, and treatment does not change the outcome when bleeding is mild.

## Why is a hepatitis B test done before rituximab?

Rituximab removes B cells and can reactivate hidden hepatitis B, causing severe hepatitis.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/haematology/immune-thrombocytopenia-who-needs-treatment-and-why/)

## Elsewhere in DurgiPedia

- [Immune thrombocytopenias: ITP and HIT](https://durgical.com/en/general-pathology/immune-thrombocytopenias-itp-and-hit/)
- [Thrombocytopenia: mechanisms](https://durgical.com/en/general-pathology/thrombocytopenia-mechanisms/)
- [Megakaryocytes and how platelets are made](https://durgical.com/en/histology/megakaryocytes-and-how-platelets-are-made/)
- [Neutropenia and low platelets: infection and bleeding precautions, and fever as an emergency](https://durgical.com/en/nursing/neutropenia-and-low-platelets-infection-and-bleeding-precautions-and-fever-as-an/)
- [Bleeding and clotting disorders: haemophilia, ITP and watching for DIC](https://durgical.com/en/nursing/bleeding-and-clotting-disorders-haemophilia-itp-and-watching-for-dic/)

## Connections

## Related 4

- [Low platelets: fake, not made, used up or pooled, and is the patient clotting?](https://durgical.com/en/haematology/low-platelets-fake-not-made-used-up-or-pooled-and-is-the-patient-clotting/)
- [The bleeding patient: plug or glue, then the PT and aPTT grid](https://durgical.com/en/haematology/the-bleeding-patient-plug-or-glue-then-the-pt-and-aptt-grid/)
- [The blood smear: what each abnormal cell is telling you](https://durgical.com/en/haematology/the-blood-smear-what-each-abnormal-cell-is-telling-you/)
- [A big spleen, and life without one](https://durgical.com/en/haematology/a-big-spleen-and-life-without-one/)

## Related conditions 4

- [Immune thrombocytopenia (ITP)](https://durgical.com/en/conditions/immune-thrombocytopenia/)
- [Systemic lupus erythematosus](https://durgical.com/en/conditions/systemic-lupus-erythematosus/)
- [Antiphospholipid syndrome](https://durgical.com/en/conditions/antiphospholipid-syndrome/)
- [Chronic lymphocytic leukaemia](https://durgical.com/en/conditions/chronic-lymphocytic-leukaemia/)

## In Pharmacology 8

- [Prednisone](https://durgical.com/en/pharmacology/prednisone/)
- [Dexamethasone](https://durgical.com/en/pharmacology/dexamethasone/)
- [Normal human immunoglobulin (IVIG)](https://durgical.com/en/pharmacology/normal-human-immunoglobulin/)
- [Anti-D immunoglobulin (Rho(D))](https://durgical.com/en/pharmacology/anti-d-immunoglobulin/)
- [Romiplostim](https://durgical.com/en/pharmacology/romiplostim/)
- [Eltrombopag](https://durgical.com/en/pharmacology/eltrombopag/)
- [Rituximab](https://durgical.com/en/pharmacology/rituximab/)
- [Tranexamic acid](https://durgical.com/en/pharmacology/tranexamic-acid/)

[← All of haematology](https://durgical.com/en/haematology/)

Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.

Sources: [Immune thrombocytopenic purpura (ITP)](https://medlineplus.gov/ency/article/000535.htm) (MedlinePlus, US National Library of Medicine, 2026); [Thrombocytopenia](https://www.nhlbi.nih.gov/health/thrombocytopenia) (National Heart, Lung, and Blood Institute (NHLBI), 2024); [Immune Globulin Intravenous (Human)(IVIG): MedlinePlus Drug Information](https://medlineplus.gov/druginfo/meds/a624082.html) (MedlinePlus (U.S. National Library of Medicine), 2025); [Platelet Disorders | MedlinePlus](https://medlineplus.gov/plateletdisorders.html) (MedlinePlus, US National Library of Medicine, 2026).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/haematology/immune-thrombocytopenia-who-needs-treatment-and-why/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/haematology/immune-thrombocytopenia-who-needs-treatment-and-why/
